We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

75 hedge funds and large institutions have $116M invested in Ampio Pharmaceuticals Inc. in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

25% more capital invested

Capital invested by funds: $92.8M → $116M (+$23.4M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less funds holding

Funds holding: 78 → 75 (-3)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

40% less call options, than puts

Call options by funds: $3.4M | Put options by funds: $5.67M

Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
2.16%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
10
Increased
35
Reduced
15
Closed
13
Calls
$3.4M
Puts
$5.67M
Net Calls
-$2.26M
Net Calls Change
-$85K

Top Buyers

Rank Fund Capital Flow
1
GIM
Guild Investment Management
California
+$714K
2
SFM
Sphera Funds Management
Israel
+$592K
3
BCM
Bridgeway Capital Management
Texas
+$306K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$263K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$255K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$1.53M
2
GCM
Goldman Capital Management
New York
-$1.28M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.24M
4
LCM
Laurion Capital Management
New York
-$796K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$782K
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$469K – – –
TA
27
Teachers Advisors
New York
$467K +$77.5K +38 +26%
CP
28
Camelot Portfolios
Ohio
$463K +$4.08K +2 +1%
AIG
29
American International Group
New York
$453K +$61.2K +30 +20%
GIA
30
GHP Investment Advisors
Colorado
$418K – – –
SM
31
Sabby Management
Florida
$397K +$42.9K +21 +15%
MLICM
32
Metropolitan Life Insurance Company (MetLife)
New York
$388K +$149K +73 +89%
AllianceBernstein
33
AllianceBernstein
Tennessee
$338K +$32.7K +16 +13%
PPA
34
Parametric Portfolio Associates
Washington
$323K +$83.7K +41 +47%
SCM
35
Stevens Capital Management
Pennsylvania
$302K +$247K +121 New
NFA
36
Nationwide Fund Advisors
Ohio
$263K +$34.7K +17 +19%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$261K +$55.1K +27 +35%
GMCM
38
Gruber & McBaine Capital Management
California
$251K – – –
VOYA Investment Management
39
VOYA Investment Management
Georgia
$234K +$190K +93 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$225K +$18.4K +9 +11%
BA
41
BlackRock Advisors
Delaware
$219K -$18.4K -9 -9%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$206K -$782K -383 -82%
Morgan Stanley
43
Morgan Stanley
New York
$201K -$382K -187 -70%
GC
44
Guggenheim Capital
Illinois
$197K -$8.16K -4 -5%
CIA
45
Capital Impact Advisors
Massachusetts
$191K +$155K +76 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$171K – – –
ProShare Advisors
47
ProShare Advisors
Maryland
$166K -$79.6K -39 -37%
WIC
48
Wood Investment Counsel
Colorado
$163K – – –
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$162K +$36.7K +18 +38%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$129K +$8.16K +4 +8%
1
2
3 4

AMPE Hedge Fund Activity: Q2 2014 in Review

75 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2014, worth a combined $116M — up 25% from $92.8M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AMPE and 10 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 35 added.

The largest buyer was Guild Investment Management, adding an estimated $714K. The largest seller was DAFNA Capital Management, cutting an estimated $1.53M.

  • 75 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2014, down from 78 in Q1 2014.
  • Funds reported $116M of Ampio Pharmaceuticals Inc. stock for Q2 2014, up 25% quarter-over-quarter.
  • 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2014 and 13 closed out, a net change of -3 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2014 was Guild Investment Management, an estimated $714K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2014 was DAFNA Capital Management, an estimated $1.53M sold.

Based on aggregated 13F filings for Q2 2014.